A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

Moderna's mRNA flu vaccine could be approved by August, but federal policy and a nonfunctional advisory committee threaten ...

Children and adolescents who die from influenza-related illness are less likely to have received the vaccine for the current season, per an analysis of pediatric deaths over eight seasons in the US.

Several companies, including GSK, Sanofi and CSL Seqirus are beginning to ship influenza vaccine for the upcoming season 2024/25 flu season. GSK has started shipping doses of its trivalent influenza ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

Since 1945, the U.S. military mandated flu vaccines—until Hegseth changed things earlier this year.

New South Wales health authorities have hailed a vaccination program that has nearly halved hospitalisations for a ...

Experts are urging Australians to roll up their sleeves as soon as the 2026 influenza vaccine becomes available, following last year's low vaccine uptake and high caseload. It comes as a fast-moving ...